EPO Patent Publication: Anti-Folate Receptor Alpha Antibodies
Summary
The European Patent Office has published patent application EP4499697A1 concerning anti-folate receptor alpha antibodies and their methods of use. The application was filed by Zymeworks BC Inc. and lists multiple inventors. This publication is part of the standard patent application process.
What changed
The European Patent Office (EPO) has published patent application EP4499697A1, titled 'Anti-Folate Receptor Alpha Antibodies and Methods of Use'. This publication, dated March 18, 2026, details a new antibody technology developed by Zymeworks BC Inc. The application includes extensive inventor lists and International Patent Classification (IPC) codes related to antibodies, pharmaceutical compositions, and their use in treating cancer.
This publication represents a step in the patenting process for Zymeworks BC Inc. and does not impose any new regulatory obligations on pharmaceutical companies or healthcare providers. Compliance officers should note this as a development in the intellectual property landscape for antibody-based therapeutics, particularly those targeting folate receptor alpha, which may be relevant for competitive intelligence or future licensing considerations.
Source document (simplified)
ANTI-FOLATE RECEPTOR ALPHA ANTIBODIES AND METHODS OF USE
Publication EP4499697A1 Kind: A1 Mar 18, 2026
Applicants
Zymeworks BC Inc.
Inventors
RICH, James R., DAVIES, Rupert H., BARNSCHER, Stuart Daniel, UROSEV, Dunja, KANG, Sukhbir Singh, CHAN, Peter Wing Yiu, DAS, Samir, HERNANDEZ ROJAS, Andrea, GENE, Robert William, YOUNG, Ada G. H., LAWN, Samuel Oliver, CHUI, Danny, BROWMAN, Duncan, CLAVETTE, Brandon
IPC Classifications
C07K 16/28 20060101AFI20260209BHEP A61K 39/395 20060101ALI20260209BHEP A61K 47/68 20170101ALI20260209BHEP A61P 35/00 20060101ALI20260209BHEP C12N 15/13 20060101ALI20260209BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.